Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanxin Xiang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Safety Research|June 15, 2026
Representation learning of crash narrative using natural language processing modelsLanxin Xiang, Feng Guo
European Journal of Immunology|June 11, 2022
Peripheral Polyfunctional PD1<sup>+</sup> CD8<sup>+</sup> T cells demonstrated strong immune protection in non-small cell lung cancerYanyan Liu, Ping Lu, Yifei Ma, et al.
Oncotargets and Therapy|October 29, 2020
Lung Carcinoma Cells Secrete Exosomal MALAT1 to Inhibit Dendritic Cell Phagocytosis, Inflammatory Response, Costimulatory Molecule Expression and Promote Dendritic Cell Autophagy via AKT/mTOR PathwayYanyan Liu, Zhucheng Yin, Ping Lu, et al.
Nanotechnology|December 29, 2023
Synergistic antibacterial attributes of copper-doped polydopamine nanoparticles: an insight into photothermal enhanced antibacterial efficacyZhiqiong Hu, Kexian Wu, Jiahong Lin, et al.
Cell Death Discovery|April 9, 2022
circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axisYanyan Liu, Haodong Zhang, Wangli Zhang, et al.
Journal of Cancer|March 14, 2022
Highly Potent Immunotoxins Targeting the Membrane-distal N-lobe of GPC3 for Immunotherapy of Hepatocellular CarcinomaJingwen Li, Lanxin Xiang, Qian Wang, et al.
Molecular Cancer Therapeutics|November 2, 2021
Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in MiceXin Chen, Yanmin Chen, Rong Liang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Safety Research|June 15, 2026
Representation learning of crash narrative using natural language processing modelsLanxin Xiang, Feng Guo
European Journal of Immunology|June 11, 2022
Peripheral Polyfunctional PD1<sup>+</sup> CD8<sup>+</sup> T cells demonstrated strong immune protection in non-small cell lung cancerYanyan Liu, Ping Lu, Yifei Ma, et al.
Oncotargets and Therapy|October 29, 2020
Lung Carcinoma Cells Secrete Exosomal MALAT1 to Inhibit Dendritic Cell Phagocytosis, Inflammatory Response, Costimulatory Molecule Expression and Promote Dendritic Cell Autophagy via AKT/mTOR PathwayYanyan Liu, Zhucheng Yin, Ping Lu, et al.
Nanotechnology|December 29, 2023
Synergistic antibacterial attributes of copper-doped polydopamine nanoparticles: an insight into photothermal enhanced antibacterial efficacyZhiqiong Hu, Kexian Wu, Jiahong Lin, et al.
Cell Death Discovery|April 9, 2022
circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axisYanyan Liu, Haodong Zhang, Wangli Zhang, et al.
Journal of Cancer|March 14, 2022
Highly Potent Immunotoxins Targeting the Membrane-distal N-lobe of GPC3 for Immunotherapy of Hepatocellular CarcinomaJingwen Li, Lanxin Xiang, Qian Wang, et al.
Molecular Cancer Therapeutics|November 2, 2021
Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in MiceXin Chen, Yanmin Chen, Rong Liang, et al.
Pageof 1